GSK (GSK)
40.86
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 6-K GSK plc For: Apr 24
April 24, 2024 6:46 AM - SEC Filing
Form 6-K GSK plc For: Apr 19
April 19, 2024 10:56 AM - SEC Filing
Form 6-K GSK plc For: Apr 17
April 17, 2024 10:53 AM - SEC Filing
Form 6-K GSK plc For: Apr 17
April 17, 2024 6:12 AM - SEC Filing
Form 6-K GSK plc For: Apr 17
April 17, 2024 6:08 AM - SEC Filing
GSK (GSK) call put ratio 12 calls to 1 put with focus on April weekly (26) 41 calls
April 16, 2024 2:29 PM - StreetInsider
Form 6-K GSK plc For: Apr 16
April 16, 2024 9:50 AM - SEC Filing
Form 6-K GSK plc For: Apr 16
April 16, 2024 6:21 AM - SEC Filing
Form 6-K GSK plc For: Apr 15
April 15, 2024 11:26 AM - SEC Filing
ViiV Healthcare announces U.S. FDA approval of Dovato for adolescents living with HIV (GSK) (PFE)
April 8, 2024 8:26 AM - StreetInsider
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
April 8, 2024 8:23 AM - BizWire
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP17.25 at Barclays
April 8, 2024 12:45 AM - StreetInsider
Form 6-K/A GSK plc For: Apr 04
April 4, 2024 7:47 AM - SEC Filing
Form 6-K GSK plc For: Apr 02
April 2, 2024 1:17 PM - SEC Filing
WuXi Biologics Reports Solid 2023 Annual Results
March 26, 2024 9:53 AM - PR NewsWire
Form 6-K GSK plc For: Mar 26
March 26, 2024 7:46 AM - SEC Filing
Form F-3ASR GSK plc
March 25, 2024 2:04 PM - SEC Filing
Form 6-K GSK plc For: Mar 25
March 25, 2024 9:38 AM - SEC Filing
Form 6-K GSK plc For: Mar 22
March 22, 2024 12:48 PM - SEC Filing
Form 6-K GSK plc For: Mar 22
March 22, 2024 12:17 PM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP20.40 at UBS
March 19, 2024 11:50 AM - StreetInsider
Form 6-K GSK plc For: Mar 18
March 18, 2024 9:57 AM - SEC Filing
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
March 16, 2024 8:00 AM - BizWire
Form 6-K GSK plc For: Mar 13
March 13, 2024 1:15 PM - SEC Filing
JPMorgan on GlaxoSmithKline (GSK:LN) (GSK): 'Dr. Sherbonou continues to see the ocular toxicity profile of Blenrep as challenging'
March 12, 2024 6:21 AM - StreetInsider
Form 6-K GSK plc For: Mar 08
March 8, 2024 12:49 PM - SEC Filing
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024 12:00 PM - BizWire
Form 6-K GSK plc For: Mar 07
March 7, 2024 6:14 AM - SEC Filing
ViiV Healthcare Announces Interim Data at CROI Indicating Superior Efficacy of Long-Acting Injectable HIV Treatment Cabenuva (Cabotegravir + Rilpivirine) Compared to Daily Oral Therapy in Individuals
March 6, 2024 12:05 PM - BizWire
Form 6-K GSK plc For: Mar 06
March 6, 2024 11:12 AM - SEC Filing
Form 6-K GSK plc For: Mar 05
March 5, 2024 1:10 PM - SEC Filing
Form IRANNOTICE GSK plc
March 5, 2024 12:31 PM - SEC Filing
Form 20-F GSK plc For: Dec 31
March 5, 2024 12:17 PM - SEC Filing
ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities
March 5, 2024 8:48 AM - BizWire
Form 6-K GSK plc For: Mar 05
March 5, 2024 6:11 AM - SEC Filing
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
March 4, 2024 1:50 PM - BizWire
Guggenheim Upgrades GlaxoSmithKline (GSK) to Buy, 'Vaccines, HIV, I&I, AND Oncology Set Up Improved 2024+ Growth'
March 4, 2024 4:30 AM - StreetInsider
Guggenheim Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy
March 4, 2024 2:29 AM - StreetInsider
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP18.30 at Morgan Stanley
March 4, 2024 2:11 AM - StreetInsider
Form 6-K GSK plc For: Mar 01
March 1, 2024 10:30 AM - SEC Filing
Form 6-K GSK plc For: Mar 01
March 1, 2024 9:56 AM - SEC Filing
Form 6-K GSK plc For: Feb 29
February 29, 2024 6:29 AM - SEC Filing
Form 6-K GSK plc For: Feb 29
February 29, 2024 6:28 AM - SEC Filing
ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV
February 28, 2024 10:04 AM - BizWire
Form 6-K GSK plc For: Feb 26
February 26, 2024 10:39 AM - SEC Filing
Form 6-K GSK plc For: Feb 26
February 26, 2024 6:39 AM - SEC Filing
Form 6-K GSK plc For: Feb 22
February 22, 2024 10:46 AM - SEC Filing
Form 6-K GSK plc For: Feb 21
February 21, 2024 6:40 AM - SEC Filing
Form 6-K GSK plc For: Feb 20
February 20, 2024 6:51 AM - SEC Filing
Deutsche Bank Reiterates Buy Rating on GlaxoSmithKline (GSK:LN) (GSK)
February 20, 2024 4:14 AM - StreetInsider
Form 6-K GSK plc For: Feb 15
February 15, 2024 12:54 PM - SEC Filing
Form 6-K GSK plc For: Feb 15
February 15, 2024 6:27 AM - SEC Filing
GSK completes acquisition of Aiolos Bio for up to $1.4 billion
February 15, 2024 2:41 AM - StreetInsider
GSK (GSK) Exercises Option to License Elsie Biotechnologies’ Discovery Platform to Find and Develop Novel Oligonucleotides
February 14, 2024 8:01 AM - StreetInsider
GSK Exercises Option to License Elsie Biotechnologies’ Discovery Platform to Find and Develop Novel Oligonucleotides
February 14, 2024 8:00 AM - BizWire
Form SC 13G/A GSK plc Filed by: DODGE & COX
February 13, 2024 1:38 PM - SEC Filing
Form 6-K GSK plc For: Feb 13
February 13, 2024 1:10 PM - SEC Filing
Form 6-K GSK plc For: Feb 13
February 13, 2024 12:44 PM - SEC Filing
Form 6-K GSK plc For: Feb 13
February 13, 2024 11:13 AM - SEC Filing
Citi Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy, 'It's Not Just a DREAMM. After 7 years, we are Upgrading to Buy'
February 13, 2024 3:18 AM - StreetInsider
Form 6-K GSK plc For: Feb 12
February 12, 2024 1:11 PM - SEC Filing
Form 6-K GSK plc For: Feb 12
February 12, 2024 12:54 PM - SEC Filing
Form 6-K GSK plc For: Feb 12
February 12, 2024 11:32 AM - SEC Filing
Form 6-K GSK plc For: Feb 12
February 12, 2024 7:05 AM - SEC Filing
The European version of Magnificent 7 is trading at a 30% discount - Goldman
February 12, 2024 6:01 AM - StreetInsider
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19.50 at Jefferies
February 10, 2024 10:31 AM - StreetInsider
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
February 8, 2024 7:00 AM - StreetInsider
Alector (ALEC) and GSK (GSK) Report Latozinemab Granted FDA Breakthrough Therapy Designation
February 7, 2024 7:02 AM - StreetInsider
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
February 7, 2024 7:00 AM - StreetInsider
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato (dolutegravir/lamivudine)
February 6, 2024 6:47 PM - BizWire
Form 6-K GSK plc For: Feb 06
February 6, 2024 7:49 AM - SEC Filing
Form 6-K GSK plc For: Feb 06
February 6, 2024 7:45 AM - SEC Filing
GSK's (GSK) RSV Vaccine, AREXVY, Accepted Under Priority Review in US
February 6, 2024 7:02 AM - StreetInsider
GSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk
February 6, 2024 7:00 AM - BizWire
Form 6-K GSK plc For: Feb 06
February 6, 2024 6:52 AM - SEC Filing
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato (dolutegravir/lamivudine)
February 5, 2024 11:00 AM - BizWire
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP19.50 at Deutsche Bank
February 5, 2024 4:00 AM - StreetInsider
Form 6-K GSK plc For: Feb 01
February 1, 2024 10:49 AM - SEC Filing
Form 6-K GSK plc For: Feb 01
February 1, 2024 10:10 AM - SEC Filing
Form 6-K GSK plc For: Feb 01
February 1, 2024 6:52 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP15.30 at JPMorgan
February 1, 2024 2:47 AM - StreetInsider
GSK fourth-quarter earnings beat expectations amid strong demand for RSV vaccine
January 31, 2024 4:26 PM - StreetInsider
Form 6-K GSK plc For: Jan 31
January 31, 2024 1:01 PM - SEC Filing
UBS Reiterates Buy Rating on GlaxoSmithKline (GSK:LN) (GSK)
January 31, 2024 5:06 AM - StreetInsider
GSK sees strong growth as Haleon split and vaccine drive pays off
January 31, 2024 2:13 AM - StreetInsider
Form 6-K GSK plc For: Jan 29
January 29, 2024 6:33 AM - SEC Filing
Form 6-K GSK plc For: Jan 29
January 29, 2024 6:27 AM - SEC Filing
Full Article List
